Jpmorgan Chase & CO Bio Sig Technologies, Inc. Transaction History

Jpmorgan Chase & CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.26 - $0.62 $270 - $646	1,042 Added 868.33%	1,162 $0
Q3 2023 Nov 14, 2023	BUY	$0.4 - $1.39 $30 - $107	77 Added 179.07%	120 $0
Q3 2021 Nov 12, 2021	BUY	$2.71 - $4.35 $116 - $187	43 New	43 $0

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $81.6M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.